Patiromer Does Not Alter Tacrolimus Pharmacokinetics in Kidney Transplant Recipients When Administered Three Hours Post–Tacrolimus

Patiromer Does Not Alter Tacrolimus Pharmacokinetics in Kidney Transplant Recipients When Administered Three Hours Post–Tacrolimus

Background. Hyperkalemia is common in kidney transplant (KTx) recipients. Patiromer, a potassium-binding polymer used to treat acute and chronic hyperkalemia, has the potential to bind charged particles in the gastrointestinal tract and thereby potentially affect the absorption of coadministered dru...

Full description

Bibliographic Details
Main Authors: Ole Martin Drevland, MSc, Marte Grasdal, MSc, Rasmus K. Carlsen, MD, Karsten Midtvedt, MD, PhD, Ida Robertsen, PhD, Trond G. Jenssen, MD, PhD, Shadi Alipour, MSc, Nils T. Vethe, PhD, Anders Åsberg, PhD, Geir Mjøen, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2024-12-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001733

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001733

Similar Items